Eckert & Ziegler will provide its Lutetium-177 chloride to support AtomVie's CDMO activities for radiopharmaceutical ...

Eckert & Ziegler SE (ISIN DE0005659700, SDAX) and AtomVie Global Radiopharma Inc. (AtomVie) today announced a global supply ...

20.03.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of this announcement. The EQS Distribution ...

Eckert & Ziegler SE and AtomVie Global Radiopharma Inc. have announced a significant global supply agreement aimed at supporting AtomVie’s ...

Scientists from Tomsk Polytechnic University, in collaboration with their colleagues, supported by the federal Priority-2030 ...

Results from the company’s Phase I/II trial showed the injectable therapy to have an effective half-life of 91.4 hours.

As federal and state governments look for ways to save money, there is one project Missouri sees fit for extra investments: ...

Priya Jacob has contributed to nuclear medicine and radiation oncology by integrating AI-driven diagnostics, optimizing PET-CT and SPECT-CT, and enhancing treatment precision. Her work in Theranostics ...

Nuclear power has long been a reliable energy source, supplying nearly 20% of electricity in the United States. While it does ...

The company’s annual review details the year’s progress on its Life-Extension Program and Major Component Replacement (MCR) ...